NanoCure selected for Innovate UK ICURe Explore
After completing ICURe Discover, our nanoneedle-based local gene delivery project NanoCure, led by Yikai Wang, moves on to the ICURe Explore programme.
Yikai Wang (entrepreneurial lead) and Ciro Chiappini have completed Innovate UK ICURe Discover for NanoCure, our nanoneedle-based local gene delivery platform and has been selected for ICURe Explore. The team will speak with clinicians, patient groups, MedTech and pharma experts to understand clinical need and adoption pathways.